Prenatal Culture-based Screening of Streptococcus Agalactiae Colonisation: Resistance Against Erythromycin and Clindamycin

Overview

Journal Eur J Clin Microbiol Infect Dis

Publisher Springer

Specialties Infectious Diseases
Microbiology

Date 2006 Jul 29

PMID 16874484

Authors

V Lavergne

M Laverdiere

A Duchesne

C Beliveau

J Delorme

A Di Zazzo

A C Labbe

Affiliations

Soon will be listed here.

References

Fitoussi F, Loukil C, Gros I, Clermont O, Mariani P, Bonacorsi S . Mechanisms of macrolide resistance in clinical group B streptococci isolated in France. Antimicrob Agents Chemother. 2001; 45(6):1889-91. PMC: 90565. DOI: 10.1128/AAC.45.6.1889-1891.2001. View

Stiller R, Padilla L, Choudhary R, Tinghitella T, Laifer S . Group B streptococcal antibiotic resistance patterns in pregnant women. Conn Med. 2003; 67(6):323-6. View

Arpin C, Daube H, Tessier F, Quentin C . Presence of mefA and mefE genes in Streptococcus agalactiae. Antimicrob Agents Chemother. 1999; 43(4):944-6. PMC: 89231. DOI: 10.1128/AAC.43.4.944. View

. ACOG Committee Opinion: number 279, December 2002. Prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol. 2002; 100(6):1405-12. DOI: 10.1016/s0029-7844(02)02629-7. View

Weiss K, Guilbault C, Cortes L, Restieri C, Low D . Genotypic characterization of macrolide-resistant strains of Streptococcus pneumoniae isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin. J Antimicrob Chemother. 2002; 50(3):403-6. DOI: 10.1093/jac/dkf146. View

Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L . Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother. 1996; 40(11):2562-6. PMC: 163576. DOI: 10.1128/AAC.40.11.2562. View

de Azavedo J, McGavin M, Duncan C, Low D, McGeer A . Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother. 2001; 45(12):3504-8. PMC: 90860. DOI: 10.1128/AAC.45.12.3504-3508.2001. View

Desjardins M, Delgaty K, Ramotar K, Seetaram C, Toye B . Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. J Clin Microbiol. 2004; 42(12):5620-3. PMC: 535282. DOI: 10.1128/JCM.42.12.5620-5623.2004. View

Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A . Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002; 51(RR-11):1-22. View

10.

de Mouy D, Cavallo J, Leclercq R, Fabre R . Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study. Antimicrob Agents Chemother. 2001; 45(8):2400-2. PMC: 90666. DOI: 10.1128/AAC.45.8.2400-2402.2001. View

11.

Gibbs R, Schrag S, Schuchat A . Perinatal infections due to group B streptococci. Obstet Gynecol. 2004; 104(5 Pt 1):1062-76. DOI: 10.1097/01.AOG.0000144128.03913.c2. View

12.

Silverman N, Morgan M, Nichols W . Antibiotic resistance patterns of group B streptococcus in antenatal genital cultures. J Reprod Med. 2001; 45(12):979-82. View

13.

Betriu C, Culebras E, Gomez M, Rodriguez-Avial I, Sanchez B, Agreda M . Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob Agents Chemother. 2003; 47(3):1112-4. PMC: 149330. DOI: 10.1128/AAC.47.3.1112-1114.2003. View

14.

Diekema D, Andrews J, Huynh H, Rhomberg P, Doktor S, Beyer J . Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci. J Clin Microbiol. 2003; 41(6):2659-61. PMC: 156484. DOI: 10.1128/JCM.41.6.2659-2661.2003. View